Side-by-side comparison of AI visibility scores, market position, and capabilities
Singapore-based pay-per-minute flexible workspace platform in 5 APAC markets; $5.12M YC W21-backed growing from $43K to $4.1M revenue enabling on-demand coworking without memberships.
Deskimo is a Singapore-based flexible workspace booking platform that provides on-demand access to coworking spaces, private offices, and meeting rooms across Singapore, Hong Kong, Indonesia, Malaysia, and the UAE — offering pay-per-minute pricing that enables remote workers, freelancers, and distributed business teams to book professional workspace without monthly memberships or long-term commitments. A Y Combinator W21 graduate, Deskimo raised $5.12 million and grew revenue from $43,400 in 2021 to $4.1 million in 2024, serving distributed workforces seeking flexible workspace access in Asia-Pacific business hubs.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.